The efficacy results of the Phase II Study of Inhaled AAT in CF patients, will be available on 3Q08. I'm guessing it will show some improvement in inflammation but not in lungs function.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.